ATE350470T1 - Durch thrombin spaltbare chimäre proteine - Google Patents
Durch thrombin spaltbare chimäre proteineInfo
- Publication number
- ATE350470T1 ATE350470T1 AT02801919T AT02801919T ATE350470T1 AT E350470 T1 ATE350470 T1 AT E350470T1 AT 02801919 T AT02801919 T AT 02801919T AT 02801919 T AT02801919 T AT 02801919T AT E350470 T1 ATE350470 T1 AT E350470T1
- Authority
- AT
- Austria
- Prior art keywords
- chimeric proteins
- thrombin
- clipable
- fibrinopeptide
- zymogen
- Prior art date
Links
- 102000037865 fusion proteins Human genes 0.000 title abstract 3
- 108020001507 fusion proteins Proteins 0.000 title abstract 3
- 108090000190 Thrombin Proteins 0.000 title abstract 2
- 229960004072 thrombin Drugs 0.000 title abstract 2
- JWICNZAGYSIBAR-LEEGLKINSA-N (4s)-4-[[2-[[(2s)-2-[[(2s)-2-[[(2s)-2-aminopropanoyl]amino]-3-carboxypropanoyl]amino]-3-hydroxypropanoyl]amino]acetyl]amino]-5-[[2-[[(2s)-3-carboxy-1-[[(2s)-1-[[1-[[(2s)-1-[[(2s)-4-carboxy-1-[[2-[[2-[[2-[[(2s)-1-[[(1s)-1-carboxy-4-(diaminomethylideneamino Chemical group NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)CNC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)C(CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](C)N)CC1=CC=CC=C1 JWICNZAGYSIBAR-LEEGLKINSA-N 0.000 abstract 2
- 101800001401 Activation peptide Proteins 0.000 abstract 2
- 102400000069 Activation peptide Human genes 0.000 abstract 2
- 102000010911 Enzyme Precursors Human genes 0.000 abstract 2
- 108010062466 Enzyme Precursors Proteins 0.000 abstract 2
- 101800000974 Fibrinopeptide A Proteins 0.000 abstract 2
- 102400000525 Fibrinopeptide A Human genes 0.000 abstract 2
- 108010022999 Serine Proteases Proteins 0.000 abstract 1
- 102000012479 Serine Proteases Human genes 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 238000003776 cleavage reaction Methods 0.000 abstract 1
- 239000002350 fibrinopeptide Substances 0.000 abstract 1
- 230000007017 scission Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6464—Protein C (3.4.21.69)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21069—Protein C activated (3.4.21.69)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- Diabetes (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0113492A FR2831170B1 (fr) | 2001-10-19 | 2001-10-19 | Proteines c modifiees activables directement par la thrombine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE350470T1 true ATE350470T1 (de) | 2007-01-15 |
Family
ID=8868473
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02801919T ATE350470T1 (de) | 2001-10-19 | 2002-10-18 | Durch thrombin spaltbare chimäre proteine |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US7589178B2 (de) |
| EP (1) | EP1436389B1 (de) |
| JP (1) | JP4355924B2 (de) |
| AT (1) | ATE350470T1 (de) |
| AU (1) | AU2002357479B2 (de) |
| CA (1) | CA2463772C (de) |
| DE (1) | DE60217377T2 (de) |
| ES (1) | ES2279010T3 (de) |
| FR (1) | FR2831170B1 (de) |
| WO (1) | WO2003035861A2 (de) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI353991B (en) | 2003-05-06 | 2011-12-11 | Syntonix Pharmaceuticals Inc | Immunoglobulin chimeric monomer-dimer hybrids |
| US7176013B2 (en) * | 2003-06-11 | 2007-02-13 | Schering Aktiengesellschaft | Modified corin molecules having substitute activation sequences and uses thereof |
| WO2004113385A1 (en) * | 2003-06-20 | 2004-12-29 | Maxygen Holdings Ltd. | Protein c propeptide variants |
| BRPI0514396A2 (pt) * | 2004-08-17 | 2009-05-12 | Csl Behring Gmbh | polipeptìdeos dependentes de vitamina k modificada |
| DE602006014126D1 (de) * | 2005-04-20 | 2010-06-17 | Viromed Co Ltd | Zusammensetzungen und verfahren zur trennung von fusionsproteinen |
| EP1728798A1 (de) | 2005-06-01 | 2006-12-06 | ZLB Behring GmbH | Blutgerinnungsfaktor X Polypeptide mit veränderten Aktivierungseigenschaften |
| EP1913144A1 (de) * | 2005-07-29 | 2008-04-23 | Ecole Polytechnique Fédérale de Lausanne | Fibrinogenmolekülvarianten-fusionsproteine |
| MX336958B (es) | 2005-11-15 | 2016-02-05 | Philadelphia Children Hospital | Metodos y composiciones para modular la hemostasia. |
| EP1820508A1 (de) | 2006-02-21 | 2007-08-22 | CSL Behring GmbH | Polypeptide des Gerinnfaktors X mit geänderten Aktivierungseigenschaften |
| ES2629099T3 (es) * | 2008-12-19 | 2017-08-07 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Derivados de serin proteasa y usos en la prevención o el tratamiento de y trastornos de la coagulación sanguinea |
| EP2199387A1 (de) | 2008-12-19 | 2010-06-23 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Serinproteasederivate und deren Verwendung zur Vorbeugung und/oder Behandlung von Blutgerinnungsstörungen |
| HRP20191305T1 (hr) | 2010-07-09 | 2019-10-18 | Bioverativ Therapeutics Inc. | Preradive jednolančane molekule i polipeptidi izrađeni koristeći iste |
| CA2838833A1 (en) | 2011-06-10 | 2012-12-13 | Biogen Idec Ma Inc. | Pro-coagulant compounds and methods of use thereof |
| US8900822B2 (en) | 2011-11-21 | 2014-12-02 | Ethicon, Inc. | Fibrinogen assay |
| US20130309753A1 (en) * | 2012-05-16 | 2013-11-21 | Saint Louis University | Recombinant auto-activating protease precursors |
| AU2013270682A1 (en) * | 2012-06-08 | 2014-12-11 | Biogen Ma Inc. | Procoagulant compounds |
| EP2863940A4 (de) | 2012-06-08 | 2016-08-10 | Biogen Ma Inc | Chimäre gerinnungsfaktoren |
| SG11201500579SA (en) | 2012-07-25 | 2015-02-27 | Catalyst Biosciences Inc | Modified factor x polypeptides and uses thereof |
| KR20150103205A (ko) | 2013-01-31 | 2015-09-09 | 화이자 인코포레이티드 | 인자 Xa 억제를 길항하기 위한 조성물 및 방법 |
| FR3001729B1 (fr) * | 2013-02-04 | 2015-03-06 | Lab Francais Du Fractionnement | Mutants du facteur x |
| WO2014160037A2 (en) | 2013-03-14 | 2014-10-02 | The Regents Of The University Of California | Activatable membrane-interacting peptides and methods of use |
| TWI828269B (zh) | 2013-03-15 | 2024-01-01 | 美商百歐維拉提夫治療公司 | 因子ix多肽調配物 |
| ES2657291T3 (es) | 2013-04-22 | 2018-03-02 | Csl Ltd. | Un complejo covalente de factor de von Willebrand y factor VIII asociado por un puente disulfuro |
| SG11201601221XA (en) | 2013-09-24 | 2016-04-28 | Pfizer | Compositions comprising heterogeneous populations of recombinant human clotting factor xa proteins |
| WO2015070014A1 (en) | 2013-11-08 | 2015-05-14 | Biogen Idec Ma Inc. | Procoagulant fusion compound |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4992373A (en) * | 1987-12-04 | 1991-02-12 | Eli Lilly And Company | Vectors and compounds for direct expression of activated human protein C |
| US5851983A (en) * | 1987-12-28 | 1998-12-22 | Teijin Limited | Elastase inhibitory polypeptide and process for production thereof by recombinant gene technology |
| US5196404B1 (en) * | 1989-08-18 | 1996-09-10 | Biogen Inc | Inhibitors of thrombin |
| GB8927722D0 (en) * | 1989-12-07 | 1990-02-07 | British Bio Technology | Proteins and nucleic acids |
| US5589571A (en) * | 1994-10-28 | 1996-12-31 | Cor Therapeutics, Inc. | Process for production of inhibited forms of activated blood factors |
| AT405516B (de) | 1997-02-27 | 1999-09-27 | Immuno Ag | Faktor x-analoge mit modifizierter proteasespaltstelle |
| US6232456B1 (en) * | 1997-10-06 | 2001-05-15 | Abbott Laboratories | Serine protease reagents and methods useful for detecting and treating diseases of the prostate |
| FR2841904B1 (fr) | 2002-07-03 | 2004-08-20 | Inst Nat Sante Rech Med | Analogues de facteurs x clivables par la thrombine |
-
2001
- 2001-10-19 FR FR0113492A patent/FR2831170B1/fr not_active Expired - Fee Related
-
2002
- 2002-10-18 US US10/492,191 patent/US7589178B2/en not_active Expired - Fee Related
- 2002-10-18 CA CA2463772A patent/CA2463772C/en not_active Expired - Fee Related
- 2002-10-18 DE DE60217377T patent/DE60217377T2/de not_active Expired - Lifetime
- 2002-10-18 ES ES02801919T patent/ES2279010T3/es not_active Expired - Lifetime
- 2002-10-18 JP JP2003538362A patent/JP4355924B2/ja not_active Expired - Fee Related
- 2002-10-18 EP EP02801919A patent/EP1436389B1/de not_active Expired - Lifetime
- 2002-10-18 WO PCT/EP2002/012191 patent/WO2003035861A2/en not_active Ceased
- 2002-10-18 AT AT02801919T patent/ATE350470T1/de not_active IP Right Cessation
- 2002-10-18 AU AU2002357479A patent/AU2002357479B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP1436389B1 (de) | 2007-01-03 |
| EP1436389A2 (de) | 2004-07-14 |
| JP4355924B2 (ja) | 2009-11-04 |
| CA2463772A1 (en) | 2003-05-01 |
| ES2279010T3 (es) | 2007-08-16 |
| WO2003035861A3 (en) | 2003-09-18 |
| WO2003035861A2 (en) | 2003-05-01 |
| CA2463772C (en) | 2014-07-29 |
| FR2831170B1 (fr) | 2004-03-19 |
| AU2002357479B2 (en) | 2008-03-06 |
| US7589178B2 (en) | 2009-09-15 |
| FR2831170A1 (fr) | 2003-04-25 |
| DE60217377T2 (de) | 2007-10-18 |
| JP2005506086A (ja) | 2005-03-03 |
| DE60217377D1 (en) | 2007-02-15 |
| US20050202527A1 (en) | 2005-09-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60217377D1 (en) | Durch thrombin spaltbare chimäre proteine | |
| Shinde et al. | Intramolecular chaperones: polypeptide extensions that modulate protein folding | |
| Basak | Inhibitors of proprotein convertases | |
| WO2005027953A3 (en) | Use of proline specific endoproteases to hydrolyse peptides and proteins | |
| ATE496123T1 (de) | Nukleinsäuren, welche für tramsmembran serin proteasen kodieren, die kodierten proteine und darauf basierende methoden | |
| WO2007031559A3 (en) | Human coagulation factor vii polypeptides | |
| UA95438C2 (ru) | Биспецифические антитела, которые замещают функциональные белки | |
| IL217488A (en) | Mt – sp1 polypeptides with specific or variable activity to the substrate with preparations and uses based on these polypeptides | |
| DE69637307D1 (de) | Aus d-aminosäuren abgeleitete cystein- und serinproteasehemmer | |
| ATE317005T1 (de) | Alkaline-phosphatase-defiziente, filamentöse pilze | |
| IN2014CN02050A (de) | ||
| WO2001004146A3 (en) | Ecarin polypeptides, polynucleotides encoding ecarin, and methods for use thereof | |
| WO2005124341A3 (en) | Stable isotope labeled polypeptide standards for protein quantitation | |
| ATE310092T1 (de) | Verfahren zur herstellung von rekombinantem trypsin | |
| DK1530637T3 (da) | Carlsberg-subtilisin-proteiner med nedsat immunogenitet | |
| IL153943A0 (en) | SUBSTRATES AND ASSAYS FOR beta-SECRETASE ACTIVITY | |
| Plaimauer et al. | ‘Shed’furin: mapping of the cleavage determinants and identification of its C-terminus | |
| MY148447A (en) | Method for amidating polypeptides with basic aminoacid d-terminals by means of specific endoproteases | |
| Fujimura et al. | Primary structure and autoproteolysis of brevilysin H6 from the venom of Gloydius halys brevicaudus | |
| Friedrich et al. | Digestive versus regulatory proteases: on calpain action in vivo. | |
| ATE493497T1 (de) | Verfahren zur herstellung von oligopeptiden | |
| EA200701778A1 (ru) | Понижающие кровяное давление пептиды из гликомакропептида | |
| DK1639104T3 (da) | Forbedrede proteaser og fremgangsmåder til fremstilling af disse | |
| WO2000001831A3 (en) | Proteases fused with variants of streptomyces subtilisin inhibitor | |
| WO2002093177A3 (en) | Assays for identifying modulators of rhomboid polypeptides |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |